Bone Biologics (BBLG) Enterprise Value (2016 - 2017)
Bone Biologics (BBLG) has disclosed Enterprise Value for 2 consecutive years, with -$1.6 million as the latest value for Q3 2017.
- On a quarterly basis, Enterprise Value fell 135.67% to -$1.6 million in Q3 2017 year-over-year; TTM through Sep 2017 was -$1.6 million, a 135.67% decrease, with the full-year FY2016 number at -$620375.0, changed N/A from a year prior.
- Enterprise Value was -$1.6 million for Q3 2017 at Bone Biologics, down from -$783014.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$620375.0 in Q4 2016 to a low of -$4.2 million in Q1 2016.